Coco, Claudio
 Distribuzione geografica
Continente #
EU - Europa 3.459
NA - Nord America 3.264
AS - Asia 2.662
SA - Sud America 533
AF - Africa 76
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 10.012
Nazione #
US - Stati Uniti d'America 3.182
DE - Germania 1.419
SG - Singapore 1.214
CN - Cina 744
SE - Svezia 532
IT - Italia 450
BR - Brasile 444
FR - Francia 209
UA - Ucraina 199
IN - India 164
GB - Regno Unito 145
IE - Irlanda 145
VN - Vietnam 117
ID - Indonesia 89
FI - Finlandia 83
TR - Turchia 67
RU - Federazione Russa 64
HK - Hong Kong 45
PL - Polonia 42
AT - Austria 38
MX - Messico 38
BE - Belgio 37
BD - Bangladesh 35
AR - Argentina 31
JP - Giappone 31
CA - Canada 30
NL - Olanda 29
IQ - Iraq 25
ZA - Sudafrica 25
KR - Corea 20
ES - Italia 13
PK - Pakistan 12
VE - Venezuela 12
CI - Costa d'Avorio 11
UZ - Uzbekistan 11
AE - Emirati Arabi Uniti 10
CZ - Repubblica Ceca 10
EC - Ecuador 10
RO - Romania 10
SA - Arabia Saudita 10
LT - Lituania 9
JO - Giordania 8
KE - Kenya 8
PE - Perù 8
CL - Cile 7
CO - Colombia 7
AU - Australia 6
IL - Israele 6
IR - Iran 6
MA - Marocco 6
PH - Filippine 6
TN - Tunisia 6
UY - Uruguay 6
SN - Senegal 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AZ - Azerbaigian 4
BO - Bolivia 4
DK - Danimarca 4
DZ - Algeria 4
KZ - Kazakistan 4
LV - Lettonia 4
MY - Malesia 4
NP - Nepal 4
AM - Armenia 3
CH - Svizzera 3
ET - Etiopia 3
EU - Europa 3
JM - Giamaica 3
KG - Kirghizistan 3
LB - Libano 3
PA - Panama 3
PY - Paraguay 3
BB - Barbados 2
CY - Cipro 2
EG - Egitto 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
HN - Honduras 2
LK - Sri Lanka 2
MD - Moldavia 2
MM - Myanmar 2
NG - Nigeria 2
PG - Papua Nuova Guinea 2
PS - Palestinian Territory 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
A1 - Anonimo 1
AL - Albania 1
AQ - Antartide 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GY - Guiana 1
HR - Croazia 1
Totale 10.003
Città #
Chandler 571
Singapore 542
Ashburn 286
Beijing 149
Dublin 145
Ann Arbor 121
Jacksonville 119
New York 118
San Mateo 101
Hefei 86
Nanjing 84
Los Angeles 83
Jakarta 79
Milan 78
Munich 74
Nürnberg 70
Wilmington 67
Cattolica 65
Hyderabad 57
São Paulo 53
Boston 52
Marseille 51
Houston 50
Izmir 48
Frankfurt am Main 45
Dearborn 42
Princeton 40
Rome 40
Dallas 39
Hong Kong 39
Ho Chi Minh City 38
Brussels 36
Moscow 35
Woodbridge 35
Chicago 32
Lawrence 31
Hanoi 30
Nanchang 30
Redwood City 28
Bremen 25
Buffalo 25
Seattle 24
Tokyo 24
Nuremberg 22
Brooklyn 21
Kent 21
London 21
Stockholm 21
Santa Clara 20
Fairfield 19
Seoul 19
Vienna 19
Norwalk 18
Orem 18
The Dalles 18
Warsaw 18
Zhengzhou 18
Helsinki 17
Boardman 16
Lancaster 16
Shenyang 16
Turku 16
Denver 15
Phoenix 15
San Francisco 15
Atlanta 14
Düsseldorf 14
Johannesburg 14
Tianjin 14
Belo Horizonte 13
Hebei 13
Kunming 13
Mountain View 13
Shanghai 13
Columbus 12
Guangzhou 12
Lauterbourg 12
Abidjan 11
Curitiba 11
Jiaxing 11
Lappeenranta 11
Leawood 11
Tashkent 11
Washington 11
Baghdad 10
Changsha 10
Council Bluffs 10
Kraków 10
Poplar 10
Rio de Janeiro 10
Toronto 10
Wroclaw 10
Bexley 9
Brasília 9
Da Nang 9
Detroit 9
Verona 9
Ankara 8
Cambridge 8
Charlotte 8
Totale 4.569
Nome #
THUNDER 2: THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI guided radiotherapy 473
Diffusion-Weighted Magnetic Resonance Imaging in Monitoring Rectal Cancer Response to Neoadjuvant Chemoradiotherapy. 248
Rectal cancer multidisciplinary treatment: evidences, consensus and perspectives. 227
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 196
Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemtoherapy and surgery. A prospective evalation of a single institutional experience. 172
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemoterapy and radioation therapy 170
Outcomes of clinical t4m0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience. 170
Evidence and research perspectives for surgeons in the European Rectal Cancer Consensus Conference (EURECA-CC2). 164
Expression and motor functional roles of voltage-dependent type 7 K(+) channels in the human taenia coli 164
International consensus guidelines on Clinical Target Volume delineation in rectal cancer 163
Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy 162
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. 162
Post-translational modulation of CD133 expression during sodium butyrate-induced differentiation of HT29 human colon cancer cells: implications for its detection 161
Polyvinylidene Fluoride Mesh (PVDF, DynaMesh®-IPOM) in The Laparoscopic Treatment of Incisional Hernia: A Prospective Comparative Trial versus Gore® ePTFE DUALMESH® Plus. 161
Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer: short-term morbidity and functional outcome. 160
The predictive value of 18F-FDG PET/CT for assessing pathological response and survival in locally advanced rectal cancer after neoadjuvant radiochemotherapy 158
Protective ileostomy creation after anterior resection of the rectum (PICARR): a decision-making exploring international survey 153
Advance in diagnosis and treatment of small bowel tumors: a single-center report 145
Anti-TNF alpha in the treatment of ulcerative colitis: a valid approach for organ-sparing or an expensive option to delay surgery? 141
Gender influences the class III and V β-tubulin ability to predict poor outcome in colorectal cancer 133
Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients 132
Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. 128
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 125
Familial microsatellite-stable non-polyposis colorectal cancer: incidence and characteristics in a clinic-based population 124
The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease 124
[D-Ala2,D-Leu5]-enkephalin (DADLE) and morphine-induced postconditioning by inhibition of mitochondrial permeability transition pore, in human myocardium 123
The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease 122
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 118
Mid-transverse colon cancer and extended versus transverse colectomy: Results of the Italian society of surgical oncology colorectal cancer network (SICO CCN) multicenter collaborative study 118
RANDOMIZED, MULTICENTER, PHASE IIB STUDY OF PREOPERATIVE CHEMORADIOTHERAPY IN T3 MID-DISTAL RECTAL CANCER: RALTITREXED + OXALIPLATIN + RADIOTHERAPY VERSUS CISPLATIN + 5-FLUOROURACIL + RADIOTHERAPY. 117
Effectiveness and Validation of the Italian Translation of the Low Anterior Resection Syndrome Score in an Italian High-Volume University Hospital 116
BRIDGE -1 TRIAL: BReak Interval Delayed surgery for Gastrointestinal Extraperitoneal rectal cancer, a multicentric phase III randomized trial 114
Anti-TNF-alpha therapies do not increase early postoperative complications in patients with inflammatory bowel disease. An Italian single-center experience. 113
The role of local excision in rectal cancer after complete response to neoadjuvant treatment 113
Tumor size as a prognostic factor in patients with stage IIa colon cancer 111
Restaging locally advanced rectal cancer with MR imaging after chemoradiation therapy. 110
CT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted. 109
The Role of Simultaneous Integrated Boost in Locally Advanced Rectal Cancer Patients with Positive Lateral Pelvic Lymph Nodes 109
RESTAGING LOCALLY ADVANCED RECTAL CANCER WITH MR IMAGING AFTER CHEMORADIATION THERAPY 107
Number of lymph nodes assessed has no prognostic impact in node-negative rectal cancers after neoadjuvant therapy. Results of the “Italian Society of Surgical Oncology (S.I.C.O.) Colorectal Cancer Network” (SICO-CCN) multicentre collaborative study 102
SPHINCTER PRESERVATION IN FOUR CONSECUTIVE PHASE II STUDIES OF PREOPERATIVE CHEMORADIATION: ANALYSIS OF 247 T3 RECTAL CANCER PATIENTS. 101
A peculiar cause of small-bowel intussusception and iron deficiency anaemia 100
The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)-cT3 rectal cancer 99
Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study 99
Anastomosis configuration and technique following ileocaecal resection for Crohn’s disease: a multicentre study 99
Effectiveness and Validation of the Italian Translation of the Low Anterior Resection Syndrome Score in an Italian High-Volume University Hospital 97
Risk factors for wound complications in patients undergoing primary closure of the perineal defect after total proctectomy 97
LONG-TERM RESULTS AFTER NEOADJUVANT RADIOCHEMOTHERAPY FOR LOCALLY ADVANCED RESECTABLE EXTRAPERITONEAL RECTAL CANCER. 97
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 96
Preoperative chemoradiotherapy affects postoperative outcomes and functional results in patients treated with transanal endoscopic microsurgery for rectal neoplasms 96
Surgical treatment of small bowel neoplasms. 93
Could the conservative approach be considered safe in the treatment of locally advanced rectal cancer in case of a clinical near-complete or complete response? A retrospective analysis 93
The 2017 Assisi Think Tank Meeting on rectal cancer: A positioning paper. 92
Body mass index and complications following major gastrointestinal surgery: A prospective, international cohort study and meta-analysis 90
Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2) 85
T1 colon cancer in the era of screening: risk factors and treatment 84
Gastro-intestinal symptoms as clinical manifestation of peritoneal and retroperitoneal spread of an invasive lobular breast cancer: Report of a case and review of the literature 82
Rectal sparing approach after preoperative radio- and/or chemotherapy (RESARCH) in patients with rectal cancer: a multicentre observational study 81
Practice parameters for early colon cancer management: Italian Society of Colorectal Surgery (Società Italiana di Chirurgia Colo-Rettale; SICCR) guidelines 81
The 2017 Assisi Think Tank Meeting on rectal cancer: A positioning paper 80
National variations in perioperative assessment and surgical management of Crohn’s disease: a multicentre study 80
Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer 79
Correction to: Long-Term Outcomes of Local Excision Following Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer (Annals of Surgical Oncology, (2021), 28, 5, (2801-2808), 10.1245/s10434-020-09243-6) 79
Segmental transverse colectomy. Minimally invasive versus open approach: results from a multicenter collaborative study 78
Practice parameters for early rectal cancer management: Italian Society of Colorectal Surgery (Società Italiana di Chirurgia Colo-Rettale; SICCR) guidelines 78
Local excision after preoperative chemoradiotherapy for rectal cancer: results of a multicenter phase II clinical trial 76
Risk factors for wound complications in patients undergoing primary closure of the perineal defect after total proctectomy 76
Local excision after preoperative chemoradiotherapy for rectal cancer: results of a multicenter phase II clinical trial 74
Long-Term Outcomes of Local Excision Following Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer 74
Four steps in the evolution of rectal cancer managements through 40 years of clinical practice: Pioneering, standardization, challenges and personalization 72
Stoma-free survival after anastomotic leak following rectal cancer resection: worldwide cohort of 2470 patients 71
A peculiar cause of small-bowel intussusception and iron deficiency anaemia 69
Individual participant data pooled-analysis of risk factors for recurrence after neoadjuvant radiotherapy and transanal local excision of rectal cancer: the PARTTLE study. 69
Neutrophil to lymphocyte ratio predicts risk of nodal involvement in T1 colorectal cancer patients 69
Rectal Sparing Approach After Neoadjuvant Therapy in Patients with Rectal Cancer: The Preliminary Results of the ReSARCh Trial 68
Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in ypT0-1 Rectal Cancer after Preoperative Radiochemotherapy: Postoperative Morbidity, Functional Results, and Long-term Oncologic Outcome 61
Completion total mesorectal excision after neoadjuvant radiochemotherapy and local excision for rectal cancer 59
Rectal Sparing Approach after preoperative Radio- and/or Chemo-therapy (ReSARCh): a prospective, multicenter, observational study 59
Global variation in the long-term outcomes of ypT0 rectal cancers 58
Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): ulcerative colitis 58
Risk factors for anastomotic leakage after anterior resection for rectal cancer (RALAR study): A nationwide retrospective study of the Italian Society of Surgical Oncology Colorectal Cancer Network Collaborative Group 57
Association of Delayed Surgery with Oncologic Long-term Outcomes in Patients with Locally Advanced Rectal Cancer Not Responding to Preoperative Chemoradiation 57
Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients 57
Minimally invasive vs. open segmental resection of the splenic flexure for cancer: a nationwide study of the Italian Society of Surgical Oncology-Colorectal Cancer Network (SICO-CNN) 55
Segmental Colonic Resection Is a Safe and Effective Treatment Option for Colon Cancer of the Splenic Flexure: A Nationwide Retrospective Study of the Italian Society of Surgical Oncology-Colorectal Cancer Network Collaborative Group 55
Chemoradiation with or without intraoperative radiation therapy in patients with locally recurrent rectal carcinoma: Prognostic factors and long term outcome 52
Textbook Outcome in Colorectal Surgery for Cancer: An Italian Version 52
Selection of locally advanced gastric carcinoma by preoperative staging laparoscopy 51
Oncological outcomes of patients not undergoing Total Mesorectal Excision after local excision: rethinking surgical indications 51
The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease 50
MLH1 and MSH2 constitutional mutations in colorectal cancer families not meeting the standard criteria for hereditary nonpolyposis colorectal cancer 50
Laparoscopic approach to recurrent incisional hernia repair: A 3-year experience 47
Surgeons' fear of getting infected by COVID19: A global survey 47
Role and Morbidity of Protective Ileostomy after Anterior Resection for Rectal Cancer: One Centre Experience and Review of Literature 46
Split course concomitant radiochemotherapy followed by brachytherapy boost in the exclusive treatment of the anal canal cancer 43
The prognostic role of anatomo-pathological factors in colorectal cancer: an univariate analysis 34
Combined-modality therapy in locally advanced primary rectal cancer 32
Other tumours of the colon and rectum 28
Rectal sparing approach after preoperative radio - and/or Chemo-therapy (ReSARCh): a prospective, multicentre, observational study 11
Totale 10.142
Categoria #
all - tutte 42.025
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.025


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021291 0 0 0 0 0 21 60 15 78 33 69 15
2021/2022717 62 39 12 87 29 30 8 93 21 49 155 132
2022/20231.478 216 212 93 248 79 189 75 121 165 20 33 27
2023/2024691 38 206 20 50 46 112 27 10 8 18 80 76
2024/20251.798 26 45 130 72 210 78 84 81 226 194 353 299
2025/20262.958 675 138 298 515 811 521 0 0 0 0 0 0
Totale 10.142